Respiratory Medicine
Volume 96, Supplement 2 , Pages S31-S35, April 2002

Development of a potent respiratory syncytial virus-specific monoclonal antibody for the prevention of serious lower respiratory tract disease in infants

  • J. YOUNG

      Affiliations

    • Research and Development, MedImmune Inc. Gaithersburg, MD, U.S.A.

No abstract is available. To read the body of this article, please view the PDF online.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 
  • f1 Correspondence should be addressed to: James Young, PhD, MedImmune, Inc., 35 W. Watkins Mill Road, Gaithersburg, MD 20878, U.S.A. Fax: +1 301 527 4203 E-mail: YoungJ@MedImmune.Com

PII: S0954-6111(02)91298-9

doi:10.1053/rmed.2002.1298

Respiratory Medicine
Volume 96, Supplement 2 , Pages S31-S35, April 2002

Article Tools